[go: up one dir, main page]

TWI670016B - Use of yeast extract - Google Patents

Use of yeast extract Download PDF

Info

Publication number
TWI670016B
TWI670016B TW104109904A TW104109904A TWI670016B TW I670016 B TWI670016 B TW I670016B TW 104109904 A TW104109904 A TW 104109904A TW 104109904 A TW104109904 A TW 104109904A TW I670016 B TWI670016 B TW I670016B
Authority
TW
Taiwan
Prior art keywords
glutathione
yeast extract
melanin production
yeast
effect
Prior art date
Application number
TW104109904A
Other languages
Chinese (zh)
Other versions
TW201620396A (en
Inventor
中川智寬
梶直人
德力基之
Original Assignee
日商興人生命科學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商興人生命科學股份有限公司 filed Critical 日商興人生命科學股份有限公司
Publication of TW201620396A publication Critical patent/TW201620396A/en
Application granted granted Critical
Publication of TWI670016B publication Critical patent/TWI670016B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14Yeasts or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

麩胱甘肽雖已知有高度的黑色素產生抑制作用或抗氧化作用等各種的美容效果,但在日本國內仍是歸類為醫藥品而無法利用於作為食品。然而,尤以近年來食品要求此種機能。 Although glutathione is known to have various cosmetic effects such as a high melanin production inhibitory effect and antioxidant effect, it is still classified as a pharmaceutical product in Japan and cannot be used as a food. However, especially in recent years, such functions are required in foods.

針對萃取自有食用經驗且安全性被認可之酵母的含麩胱甘肽之酵母萃取物,利用小鼠B16黑色素瘤細胞來確認抑制黑色素產生的效果,結果確認了:與同濃度的麩胱甘肽單質相比可獲得2倍以上之優良的黑色素產生抑制效果。 A mouse B16 melanoma cell was used to confirm the effect of inhibiting melanin production on a glutathione-containing yeast extract extracted from a yeast that has been edible and recognized for its safety. The results confirmed that the same concentration of glutathione Compared with peptide simple substance, the melanin production inhibitory effect can be more than doubled.

Description

酵母萃取物之用途 Uses of yeast extract

本發明提供利用有食用經驗且安全性被認可的酵母,於菌體培養後萃取出酵母萃取物,利用所得酵母萃取物及麩胱甘肽的黑色素產生抑制劑。 The invention provides the use of yeast with edible experience and recognized safety, extracting a yeast extract after bacterial cell culture, and using the obtained yeast extract and a melanin production inhibitor of glutathione.

抗衡因年齡增長、壓力、暴露於紫外線等原因所引起的色斑、皺紋、鬆弛等皮膚症狀的惡化而美麗地保持肌膚的美觀,對於女性而言為關切的要事。因此,吾人謀求用以預防或改善皮膚症狀的惡化之手段,迄此已完成各種研究。特別是,色斑、斑點、日曬後之色素沉澱等已知係因存在於皮膚之色素細胞(黑色素細胞)的活化使黑色素生成顯著亢進而引起。作為用以預防或改善此等色素沉澱所涉及之皮膚症狀的惡化的素材之一,已知有麩胱甘肽。 It is important for women to counteract the deterioration of skin symptoms such as pigmentation, wrinkles, and sagging caused by age, stress, and exposure to ultraviolet rays, and to maintain beautiful skin. Therefore, I have sought various means for preventing or improving the deterioration of skin symptoms, and various studies have been completed so far. In particular, it is known that pigmentation, spots, pigmentation after sun exposure, and the like are caused by the activation of pigment cells (melanocytes) existing in the skin, which significantly increases melanin production. As one of the materials for preventing or improving the deterioration of the skin symptoms involved in these pigmentation, glutathione is known.

麩胱甘肽係指麩胺酸、半胱胺酸、甘胺酸此三種胺基酸鍵結而成的三肽,具有作為在細胞內保護細胞免於活性氧或過氧化物質侵害之抗氧化物質的作用、或將異物排出至細胞外之解毒作用等生物體內重要的作用。在肌膚中,活 性氧亦屬黑色素色素的產生原因,據認為藉由麩胱甘肽的抗氧化作用可抑制色斑、色素沉澱。 Glutathione refers to a tripeptide that is a bond of three amino acids, glutamic acid, cysteine, and glycine. It has the antioxidant function of protecting cells from reactive oxygen or peroxidants in cells Important effects in living organisms, such as the action of substances, or the detoxification of foreign matter that is excreted out of cells. In the skin, live Sexual oxygen is also the cause of melanin pigmentation, and it is thought that pigmentation and pigmentation can be suppressed by the antioxidant effect of glutathione.

[先前技術文獻] [Prior technical literature]

[專利文獻] [Patent Literature]

[專利文獻1]日本特開2002-29920號公報 [Patent Document 1] Japanese Patent Laid-Open No. 2002-29920

麩胱甘肽雖已知有高度的黑色素產生抑制作用或抗氧化作用等各種的美容效果,但在日本仍是歸類為醫藥品而無法利用於作為食品。 Although glutathione is known to have various cosmetic effects such as a high melanin production inhibitory effect and antioxidant effect, it is still classified as a pharmaceutical in Japan and cannot be used as a food.

本發明之課題為提供作為食品、或醫藥品等之安全性高且美白效果優良的黑色素產生抑制劑。 An object of the present invention is to provide a melanin production inhibitor having high safety and excellent whitening effect as a food or a pharmaceutical.

吾人有鑒於此實情而致力重複研究,發現:利用有食用經驗且安全性受認可的圓酵母(Torula yeast),於菌體培養後萃取出酵母萃取物,所得富含麩胱甘肽之酵母萃取物具有較麩胱甘肽單獨時更高的黑色素產生抑制效果,而完成本發明。 In view of this fact, I have been working hard to repeat the research and found that: Torula yeast, which has experience in food consumption and is recognized as safe, extracts yeast extract after bacterial culture, and the resulting glutathione-rich yeast extract The compound has a higher melanin production inhibitory effect than that of glutathione alone, and completed the present invention.

亦即,本發明提供: (1)一種黑色素產生抑制劑,其含有酵母萃取物及麩胱甘肽;(2)一種飲食品,其含有如(1)之黑色素產生抑制劑;(3)一種化妝品,其含有如(1)之黑色素產生抑制劑;(4)一種醫藥品,其含有如(1)之黑色素產生抑制劑。 That is, the present invention provides: (1) a melanin production inhibitor containing yeast extract and glutathione; (2) a food and drink product containing a melanin production inhibitor such as (1); (3) a cosmetic product containing (1) ), A melanin production inhibitor; (4) A pharmaceutical product containing a melanin production inhibitor such as (1).

針對萃取自有食用經驗且安全性受認可之食用酵母的含麩胱甘肽之酵母萃取物,利用小鼠B16黑色素瘤細胞來確認黑色素產生抑制的效果,結果確認了:與同濃度的麩胱甘肽單獨時相比可獲得2倍以上之優良的黑色素產生抑制效果。 A mouse B16 melanoma cell was used to confirm the effect of suppressing melanin production on a glutathione-containing yeast extract extracted from a edible yeast that has experience in food consumption and is recognized for its safety. Compared to glycine alone, it has more than two times better melanin production inhibitory effect.

1‧‧‧對照組 1‧‧‧control group

2‧‧‧麩胱甘肽 2‧‧‧glutathione

3‧‧‧本案發明(含麩胱甘肽之酵母萃取物) 3‧‧‧ Invention of the case (yeast extract containing glutathione)

4‧‧‧正對照(乳酸鈉) 4‧‧‧ Positive control (sodium lactate)

圖1顯示黑色素產生抑制效果。 Figure 1 shows the melanin production inhibitory effect.

本發明所使用的酵母可無特別限制地使用。舉例來說,若萃取自含有麩胱甘肽的酵母時,由於可獲得含酵母萃取物與麩胱甘肽的含麩胱甘肽之酵母萃取物,因而較佳。特佳之酵母係一般名稱稱為「圓酵母」的高蛋白假絲酵母(Candida utilis)。酵母的培養形式不特別限制,一般係使用批次培養、或連續培養任一種。培養基亦可使用一般所使用者。舉例來說,作為碳源,可使用葡萄糖、乙酸、乙醇、甘油、糖蜜、亞硫酸紙漿廢液等。作為氮源,可使用尿素、氨、硫酸銨、 氯化銨、硝酸鹽等。就磷酸、鉀、鎂源而言,亦以過磷酸石灰、磷酸銨、氯化鉀、氫氧化鉀、硫酸鎂、氯化鎂等一般的工業用原料為佳。此外,一般係添加鋅、銅、錳、鐵離子等無機鹽。又,亦有添加維生素、胺基酸、核酸相關物質等者。尚可添加酪蛋白、酵母萃取物、肉萃取物、腖等的有機物。培養溫度為21~37℃,較佳為25~34℃;pH為3.0~8.0,尤以3.5~7.0為佳。由於胺基酸或核酸的生產性會隨培養條件而變動,因此因應目標之酵母萃取物的製品規格來進行條件設定。 The yeast used in the present invention can be used without particular limitation. For example, when extracted from a glutathione-containing yeast, it is preferable to obtain a glutathione-containing yeast extract containing a yeast extract and glutathione. A particularly good yeast line is Candida utilis, commonly known as "round yeast". The culture form of the yeast is not particularly limited, and generally, either batch culture or continuous culture is used. The medium can also be used by ordinary users. For example, as the carbon source, glucose, acetic acid, ethanol, glycerin, molasses, sulfurous acid pulp waste liquid, and the like can be used. As the nitrogen source, urea, ammonia, ammonium sulfate, Ammonium chloride, nitrate, etc. As for the sources of phosphoric acid, potassium, and magnesium, general industrial raw materials such as superphosphate lime, ammonium phosphate, potassium chloride, potassium hydroxide, magnesium sulfate, and magnesium chloride are also preferred. In addition, inorganic salts such as zinc, copper, manganese, and iron ions are generally added. In addition, vitamins, amino acids, and nucleic acid-related substances are also added. Organic substances such as casein, yeast extract, meat extract, coriander can still be added. The culture temperature is 21 to 37 ° C, preferably 25 to 34 ° C; the pH is 3.0 to 8.0, and preferably 3.5 to 7.0. Since the productivity of amino acids or nucleic acids varies depending on the culture conditions, the conditions are set in accordance with the product specifications of the target yeast extract.

於菌體培養後由酵母菌體進行萃取。萃取法無特別限制,一般而言,可藉由自消化法、熱水萃取法、酵素萃取法、酸或鹼萃取法、或此等之組合來進行。 After the bacterial cells are cultured, the yeast cells are extracted. The extraction method is not particularly limited, and generally, it can be performed by a self-digestion method, a hot water extraction method, an enzyme extraction method, an acid or alkali extraction method, or a combination thereof.

藉由自消化進行萃取時,例如,在55℃下攪拌4小時。如採酵素萃取法,係以細胞壁溶解酵素或蛋白酶等進行攪拌萃取。如採酸萃取法,係以硫酸等調整成酸性後進行萃取。如採鹼萃取法,則調整成鹼性後進行萃取。於自消化後(例如在55℃下攪拌4小時),亦可採進行酵素萃取等的組合。 When extraction is performed by autodigestion, for example, it is stirred at 55 ° C for 4 hours. For example, the enzyme extraction method uses cell wall to dissolve enzymes or proteases for stirring extraction. For example, the acid extraction method is performed after the acid is adjusted to be acidic with sulfuric acid or the like. In the case of alkali extraction, extraction is performed after adjustment to alkalinity. After self-digestion (for example, stirring at 55 ° C for 4 hours), a combination of enzyme extraction and the like may be used.

萃取後,以離心分離將酵母殘渣分離,於濃縮後進行冷凍乾燥或熱風乾燥,由此可得含麩胱甘肽之酵母萃取物。酵母萃取物中所含之麩胱甘肽可為還原型麩胱甘肽、氧化型麩胱甘肽、及此等之混合物的任一種。酵母萃取物中的麩胱甘肽含量,只要在酵母萃取物中含有麩胱甘肽即可。例如為含有3質量%以上,較佳為10質量%以上之麩胱甘肽的酵母萃取物。更佳為在乾燥酵母萃取物中含有15質量%以上之麩胱甘肽的酵母萃取物。為使酵母萃取物中的麩胱甘肽含量達 15%以上,培養酵母中的麩胱甘肽含量愈高愈佳,據此,依前述之萃取法萃取出酵母萃取物者的效率較好。作為提高酵母中的麩胱甘肽含量之方法,宜為周知之方法。例如有對培養基中添加鋅離子的方法(日本特開2000-279164號公報);以鎘耐性、巨環內酯系抗生物質耐性為指標的富含麩胱甘肽之酵母株的取得方法(日本特開2006-42637號公報、日本特開2006-42638號公報)。如日本特開2011-103789號公報所述,亦可藉由變異酵母菌體萃取獲得。又,亦可使用一般販售的酵母萃取物。例如有KOHJIN Life Sciences公司製「Hithionextract」YH-15、YH-D18等。 After extraction, the yeast residue is separated by centrifugation, and concentrated and then freeze-dried or hot air dried to obtain a yeast extract containing glutathione. The glutathione contained in the yeast extract may be any of reduced glutathione, oxidized glutathione, and mixtures thereof. The content of glutathione in the yeast extract may be any content as long as the glutathione is contained in the yeast extract. For example, it is a yeast extract containing glutathione of 3 mass% or more, Preferably it is 10 mass% or more. More preferably, it is a yeast extract which contains 15 mass% or more of glutathione in a dry yeast extract. In order to maximize the content of glutathione in yeast extract Above 15%, the higher the content of glutathione in the cultured yeast, the better. According to this, the efficiency of extracting the yeast extract according to the aforementioned extraction method is better. As a method for increasing the content of glutathione in yeast, a known method is preferred. For example, there is a method of adding zinc ions to a culture medium (Japanese Patent Laid-Open No. 2000-279164); a method for obtaining a glutathione-rich yeast strain using cadmium resistance and macrolide resistance as indicators (Japan) (Japanese Laid-Open Patent Publication No. 2006-42637, Japanese Laid-Open Patent Publication No. 2006-42638). As described in Japanese Patent Application Laid-Open No. 2011-103789, it can also be obtained by extraction of mutant yeast cells. Alternatively, a commercially available yeast extract may be used. For example, there are "Hithionextract" YH-15 and YH-D18 manufactured by KOHJIN Life Sciences.

麩胱甘肽濃度的測定方法係以DTNB-HPLC法(Journal of Chromatography,194(1980)424-428)進行。本案的麩胱甘肽含量係指合併還原型及氧化型麩胱甘肽的總麩胱甘肽含量。 The method for measuring the glutathione concentration was performed by a DTNB-HPLC method (Journal of Chromatography, 194 (1980) 424-428). The glutathione content in this case refers to the total glutathione content of a combination of reduced and oxidized glutathione.

本發明中,由於酵母萃取物中之成分與麩胱甘肽的加乘效果,藉由對於麩胱甘肽含量較低、或不含麩胱甘肽的酵母萃取物添加麩胱甘肽亦可製成含麩胱甘肽之酵母萃取物。 In the present invention, due to the synergistic effect of the ingredients in the yeast extract and glutathione, it is also possible to add glutathione to a yeast extract that has a low content of glutathione or does not contain glutathione Made of yeast extract containing glutathione.

本發明提供以含有上述之本發明富含麩胱甘肽之酵母萃取物為特徵的飲食品、化妝品、皮膚外用劑或醫藥品。 The present invention provides a food or drink, a cosmetic, a skin external preparation, or a medicinal product characterized by containing the above-mentioned glutathione-rich yeast extract of the present invention.

本發明中的飲食品係指摻合有上述組成物的食品、飲品、嗜好品、補給品等經口攝取者。其形態不特別限定,可以採用:可製成麵包類、麵類等主食者; 可製成乳酪、火腿、維也納香腸、魚貝類加工品等副食者;果汁飲料、碳酸飲料、乳飲料等飲料;餅乾、蛋糕、果凍、布丁、糖果、優格等嗜好品等。又,作為補給品之形態亦不特別限定,亦可採用錠劑、膠囊、軟膠囊、營養飲料狀的形態。 The food and drink in the present invention refers to a person who orally ingests foods, drinks, hobby products, and supplements with the above composition blended. The form is not particularly limited, and can be used: those who can make staple foods such as bread and noodles; It can be made into non-staple food such as cheese, ham, viennese sausage, processed fish and shellfish; fruit juice, carbonated beverage, milk beverage and other beverages; biscuits, cake, jelly, pudding, candy, yogurt, etc. Moreover, the form of a supplement is not specifically limited, The form of a tablet, a capsule, a soft capsule, and a nutrition drink can also be used.

飲食品中的上述組成物的摻合量只要具有黑色素產生抑制效果則不特別限定,例如含麩胱甘肽之酵母萃取物,相對於飲食品的質量100g含有10pg~20g即可。其中較佳為100pg~2g,更佳為10ng~500mg。 The blending amount of the above composition in food and drink is not particularly limited as long as it has a melanin production suppressing effect. For example, a yeast extract containing glutathione may contain 10 pg to 20 g with respect to 100 g of food and drink. Among them, it is preferably 100 pg to 2 g, and more preferably 10 ng to 500 mg.

本發明之化妝品係指摻合有上述組成物的化妝水、乳液、粉底、口紅等。 The cosmetic of the present invention refers to a lotion, an emulsion, a foundation, a lipstick, and the like mixed with the above composition.

組成物的摻合量不特別限定,例如相對於上述組成物的質量100g含有10pg~20g即可。其中較佳為100pg~2g,更佳為10ng~500mg。 The blending amount of the composition is not particularly limited, and for example, it may contain 10 pg to 20 g with respect to 100 g of the mass of the composition. Among them, it is preferably 100 pg to 2 g, and more preferably 10 ng to 500 mg.

又本發明可作為皮膚外用劑等的醫藥品使用。雖意指摻合有上述組成物的洗劑、乳劑、軟膏、噴霧劑、貼劑(材)等之形狀者,惟其形態不特別限定,只要可發揮本發明目的之效果即可,可為任意形態。 The present invention can also be used as a pharmaceutical for external use on skin. Although it means a shape of a lotion, an emulsion, an ointment, a spray, a patch (material) and the like in which the above composition is blended, the form is not particularly limited as long as the effect of the purpose of the present invention can be exhibited, it may be any form.

醫藥品中的組成物的摻合量不特別限定,例如富含麩胱甘肽之酵母萃取物,相對於組成物的質量100g10pg~20g即可。其中較佳為100pg~2g,更佳為10ng~500mg。 The blending amount of the composition in the pharmaceutical is not particularly limited. For example, a yeast extract rich in glutathione may be 10 pg to 20 g with respect to the mass of the composition. Among them, it is preferably 100 pg to 2 g, and more preferably 10 ng to 500 mg.

[實施例] [Example]

以下舉出實施例對本發明更詳細加以說明,惟本發明不受此等實施例所限定。 The following examples are used to describe the present invention in more detail, but the present invention is not limited by these examples.

(實施例1) (Example 1)

含麩胱甘肽之酵母萃取物的製造 Manufacture of glutathione-containing yeast extract

(酵母的培養) (Culture of yeast)

預先在含有YPD培養基(酵母萃取物1%、聚腖2%、葡萄糖2%)的三角燒瓶中將Candida utilis CS7529株(FERMP-3340)進行種母培養,在30L容量發酵槽中,於18L培養基中將其進行1~2%的接菌。培養基組成使用葡萄糖4%、磷酸一銨0.3%、硫酸銨0.161%、氯化鉀0.137%、硫酸鎂0.08%、硫酸銅1.6ppm、硫酸鐵14ppm、硫酸錳16ppm、硫酸鋅14ppm。培養條件採用pH4.0、培養溫度30℃、通氣量1vvm、攪拌600rpm進行,並添加氨來進行pH的控制。進行16小時的菌體培養後,回收培養液,藉由離心分離集菌,而得到180g的濕潤酵母菌體。 Candida utilis CS7529 strain (FERMP-3340) was seed-cultured in an Erlenmeyer flask containing YPD medium (1% yeast extract, 2% polyfluorene, and 2% glucose) in a 30L capacity fermentation tank in 18L It was inoculated with 1 ~ 2% in the medium. The composition of the culture medium was 4% glucose, 0.3% monoammonium phosphate, 0.161% ammonium sulfate, 0.137% potassium chloride, 0.08% magnesium sulfate, 1.6 ppm copper sulfate, 14 ppm iron sulfate, 16 ppm manganese sulfate, and 14 ppm zinc sulfate. The culture conditions were performed using pH 4.0, a culture temperature of 30 ° C, an aeration volume of 1 vvm, and stirring at 600 rpm, and addition of ammonia to control the pH. After 16 hours of bacterial cell culture, the culture solution was recovered and the bacteria were collected by centrifugation to obtain 180 g of moist yeast cells.

(酵母萃取物的萃取) (Extraction of yeast extract)

藉由將菌體培養後的濕潤酵母菌體懸浮於蒸餾水並重複離心分離來進行清洗。清洗後再度將濕潤菌體懸浮於蒸餾水、或將經冷凍乾燥或熱風乾燥的乾燥菌體懸浮於蒸餾水,並調整為以下條件來進行萃取物萃取。 The moist yeast cells after culturing the cells were suspended in distilled water and repeatedly centrifuged to perform washing. After washing, the wet bacteria were suspended in distilled water again, or the freeze-dried or hot air-dried bacteria were suspended in distilled water, and adjusted to the following conditions to extract the extract.

自消化:以1N HCl調整為pH5.0後,在55℃下攪拌4小時 Self-digestion: After adjusting to pH 5.0 with 1N HCl, stir at 55 ° C for 4 hours

酵素萃取:以1N NaOH調整為pH7後,以細胞壁溶解酵素(Tunicase)或蛋白酶在55℃下進行4小時攪拌萃取 Enzyme extraction: After adjusting to pH 7 with 1N NaOH, use cell wall-dissolving enzyme (Tunicase) or protease to perform extraction at 55 ° C for 4 hours with stirring.

酸萃取:以1N硫酸調整為pH2以下後,在65℃下進行2分鐘攪拌萃取 Acid extraction: After adjusting to pH 2 or less with 1N sulfuric acid, perform stirring extraction at 65 ° C for 2 minutes

鹼萃取:以2N NaOH調整為pH13後,在70℃下進行20分鐘攪拌萃取 Alkali extraction: After adjusting to pH 13 with 2N NaOH, carry out stirring extraction at 70 ° C for 20 minutes

(酵母萃取物的乾燥) (Drying of yeast extract)

萃取後以離心分離分離酵母殘渣,並將萃取物濃縮後,進行冷凍乾燥或熱風乾燥而得到含麩胱甘肽之酵母萃取物。還原型麩胱甘肽含量為15.51%、麩胱甘肽含量(總麩胱甘肽含量)為17.68%。 After extraction, the yeast residue is separated by centrifugation, and the extract is concentrated, and then freeze-dried or hot air dried to obtain a glutathione-containing yeast extract. The reduced glutathione content was 15.51%, and the glutathione content (total glutathione content) was 17.68%.

(黑色素產生抑制效果的確認) (Confirmation of melanin production suppressing effect)

依循以下程序測定黑色素產生抑制效果。 The melanin production inhibitory effect was measured by the following procedure.

<黑色素產生抑制效果的驗證> <Verification of melanin production inhibitory effect>

將B16小鼠黑色素瘤細胞播種於6井平板(2×104/井),進行24小時前培養(5%CO2、37℃)。培養液使用含5%胎牛血清的D-MEM培養基。其後,更換為新鮮培養基,其中添加麩胱甘肽(比較例1)、富含麩胱甘肽之酵母萃取物(實施例1)使最終濃度以還原型麩胱甘肽換算計成為1.0mM,及已知有黑色素產生抑制效果的乳酸鈉(比較例2)使最終濃度成為50mM。在播種後第4日去除培養基,將平板以PBS(磷酸緩衝生理食鹽水)清洗後,以0.25%胰蛋白酶EDTA剝離,並藉由離心(10000rpm、3min)操作回收團粒(細胞)。回收之團粒以PBS清洗2次後,以1mL的PBS調整細胞浮游液而將0.8mL使用於黑色素量的測定、將0.2mL使用於蛋白質的定量。 B16 mouse melanoma cells were seeded on a 6-well plate (2 × 10 4 / well) and cultured 24 hours before (5% CO 2 , 37 ° C.). D-MEM medium containing 5% fetal bovine serum was used as the culture medium. Thereafter, it was replaced with a fresh medium, and glutathione (Comparative Example 1) and a yeast extract rich in glutathione (Example 1) were added so that the final concentration became 1.0 mM in terms of reduced glutathione. And sodium lactate (Comparative Example 2) which is known to have a melanin production inhibitory effect, so that the final concentration becomes 50 mM. On the fourth day after sowing, the medium was removed, the plate was washed with PBS (phosphate-buffered saline), and then stripped with 0.25% trypsin EDTA, and pellets (cells) were recovered by centrifugation (10,000 rpm, 3 min). After the recovered pellets were washed twice with PBS, the cell suspension was adjusted with 1 mL of PBS, and 0.8 mL was used to measure the amount of melanin, and 0.2 mL was used to quantify the protein.

將作為黑色素量的測定用之回收團粒以150μL的1N NaOH熔解(100℃、10分),利用微盤分析儀(microplate reader)測定405nm的吸光度。作為蛋白質的回收定量用之團粒以BCA法進行蛋白質的定量。以添加水者為對照組,求取令對照組為100%時,添加比較例1、2而培養的細胞之每單位蛋白質的黑色素量作為黑色素生成率。 The recovered pellets used for measuring the amount of melanin were dissolved in 150 μL of 1N NaOH (100 ° C., 10 minutes), and the absorbance at 405 nm was measured using a microplate reader. The pellets used for protein recovery and quantification were quantified by the BCA method. The water-added person was used as a control group. When the control group was set to 100%, the amount of melanin per unit protein of the cells cultured in Comparative Examples 1 and 2 was added as the melanin production rate.

將實施例1之結果示於圖1。如圖1所示,就麩胱甘肽單獨時(比較例1),黑色素產生抑制率與對照組相比為約40%,相對於此,本案發明之富含麩胱甘肽之酵母萃取物的黑色素產生抑制率與對照組相比為約85%,可判斷與麩胱甘肽單獨時相比具有2倍以上的黑色素產生抑制效果。可認為此係因麩胱甘肽與酵母萃取物中的麩胱甘肽以外之成分顯示加乘效果所致。因此,本發明之富含麩胱甘肽之酵母萃取物可作為食品使用,並可發揮優良的黑色素產生抑制效果,而有用於作為黑色素產生抑制劑。 The results of Example 1 are shown in FIG. 1. As shown in FIG. 1, when glutathione is alone (Comparative Example 1), the melanin production inhibition rate is about 40% compared with the control group. In contrast, the glutathione-rich yeast extract of the present invention is The melanin production inhibitory rate was about 85% compared with the control group, and it was judged that the melanin production inhibitory effect was twice or more than that of glutathione alone. It is considered that this is because the components other than glutathione in the glutathione and the yeast extract exhibit a multiplier effect. Therefore, the glutathione-enriched yeast extract of the present invention can be used as a food, and can exhibit an excellent melanin production inhibitory effect, and is useful as a melanin production inhibitor.

Claims (1)

一種酵母萃取物之用途,係使用酵母萃取物以製造黑色素產生抑制劑,該黑色素產生抑制劑含有酵母萃取物及麩胱甘肽,該酵母萃取物含有15質量%以上的麩胱甘肽。A use of a yeast extract is to use a yeast extract to produce a melanin production inhibitor. The melanin production inhibitor contains a yeast extract and glutathione, and the yeast extract contains 15% by mass or more of glutathione.
TW104109904A 2014-03-31 2015-03-27 Use of yeast extract TWI670016B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014070964 2014-03-31
JP2014-070964 2014-03-31

Publications (2)

Publication Number Publication Date
TW201620396A TW201620396A (en) 2016-06-16
TWI670016B true TWI670016B (en) 2019-09-01

Family

ID=54240197

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104109904A TWI670016B (en) 2014-03-31 2015-03-27 Use of yeast extract

Country Status (3)

Country Link
JP (1) JPWO2015151867A1 (en)
TW (1) TWI670016B (en)
WO (1) WO2015151867A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102876448B1 (en) * 2020-12-30 2025-10-24 주식회사 삼양사 Yeast extract containing tripeptide and method thereof
JP7089305B1 (en) * 2021-04-15 2022-06-22 株式会社ファーマフーズ Skin whitening composition
EP4659758A1 (en) 2023-01-31 2025-12-10 Mitsubishi Corporation Life Sciences Limited Anti-aging composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002020300A (en) * 2000-07-07 2002-01-23 Ichimaru Pharcos Co Ltd Cosmetic composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040992B2 (en) * 1998-06-11 2000-05-15 株式会社ファンケル Food composition
JP2001354570A (en) * 2000-06-15 2001-12-25 Ichimaru Pharcos Co Ltd Immunoactivating agent and cosmetic using the same
JP2003252742A (en) * 2002-02-28 2003-09-10 Kose Corp Melanocyte dendrite formation inhibitor and skin care preparation containing the same
JP2006347975A (en) * 2005-06-17 2006-12-28 Bio Solutions:Kk Oral composition for cardiovascular disease prophylaxis and amelioration
JP2006347988A (en) * 2005-06-20 2006-12-28 Pola Chem Ind Inc Cosmetics containing natural yeast extract
JP5561889B2 (en) * 2006-09-19 2014-07-30 株式会社アリミノ Active oxygen radical removing composition and hair-containing active oxygen radical removing agent containing the same
JP2008303180A (en) * 2007-06-08 2008-12-18 Noevir Co Ltd Skin-lightening agent, skincare preparation for external use, and functional oral composition
JP2009107962A (en) * 2007-10-29 2009-05-21 Asahi Breweries Ltd Yeast extract-containing composition
CN102008426A (en) * 2009-09-08 2011-04-13 上海利盛生化有限公司 Cosmetic composition with function of eliminating free radical
EP2554656B1 (en) * 2010-03-26 2018-05-16 Asahi Group Holdings, Ltd. Method for culturing yeast

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002020300A (en) * 2000-07-07 2002-01-23 Ichimaru Pharcos Co Ltd Cosmetic composition

Also Published As

Publication number Publication date
TW201620396A (en) 2016-06-16
WO2015151867A1 (en) 2015-10-08
JPWO2015151867A1 (en) 2017-04-13

Similar Documents

Publication Publication Date Title
TWI652992B (en) Yeast-derived seasoning, method for producing yeast protein composition, and yeast-derived seasoning
Alsayadi et al. Antioxidant potency of water kefir
JP4163631B2 (en) Fermentation composition of spicy varieties of chili pepper and its use
JP5467433B2 (en) Seaweed fermentation composition and method for producing the same
CN110249055A (en) Fermentation material and its manufacturing method
WO2018225557A1 (en) Extracellular polysaccharide of lactic acid bacteria and use thereof
JP4854199B2 (en) Functional material obtained by re-fermenting liquefied sake lees
TWI670016B (en) Use of yeast extract
JP6281890B2 (en) Use of Torula yeast-derived glucosylceramide as a whitening agent
CN1917856B (en) Oral skin moisturizer and functional food and beverage
JP2018033424A (en) Taste modifying composition
JP6172700B2 (en) Use of Torula yeast-derived glucosylceramide as a fibroblast growth promoter
TWI679982B (en) Use of lactic acid bacteria fermented material for producing inhibitor of pentosine
TW202317166A (en) Uses of golden passion fruit ferment for improving skin condition and anti-photoaging
JP6301522B1 (en) Antihypertensive composition and method for producing the same
JP6261031B2 (en) Use of Torula yeast-derived glucosylceramide as a colon cancer inhibitor
JP6629512B2 (en) Composition for promoting collagen production containing glucosylceramide derived from Torula yeast
KR20220130967A (en) Fermented extract of Young Antler with Enhanced Anti-oxidant Activity
JP6397814B2 (en) Method for producing copper-containing yeast extract, method for producing food, and method for restoring green color of vegetable
KR20180065825A (en) Fermentation Condiment of Sea Tangle Extract Method
CN105821099A (en) Process for preparing antioxidant peptides from pinctada martensii by adopting fermentation method
JP2019136027A (en) Fermentation product
JP2019033706A (en) Method for producing D-amino acid
KR20180067897A (en) Method for producing quinoa microbial fermentation rich in l-carnitine
JP2025022429A (en) Lactic acid bacteria fermentation composition and method for producing same